BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Durbin AP, Skiadopoulos MH, McAuliffe JM, Riggs JM, Surman SR, Collins PL, Murphy BR. Human parainfluenza virus type 3 (PIV3) expressing the
hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy. J Virol 2000
Aug;74(15):6821­31.
Durek C, Rusch­Gerdes S, Jocham D, Bohle A. Sensitivity of BCG to modern antibiotics. Eur Urol 2000; 37 Suppl 1:21­25.
Duval B, Boulianne N, De Serres G, Laflamme N, De Wals P, Masse R, Trudeau G, Delage G, Desjardins L. Comparative immunogenicity under field
conditions of two recombinant hepatitis B vaccines in 8­10­year­old children. Vaccine 2000;1467­72.
Earn DJ, Rohani P, Bolker BM, Grenfell BT. A simple model for complex dynamical transitions in epidemics [see comments]. Science 2000;667­70.
Eder JP, Kantoff PW, Roper K, Xu GX, Bubley GJ, Boyden J, Gritz L, Mazzara G, Oh WK, Arlen P, et al. A phase I trial of a recombinant vaccinia virus
expressing prostate­specific antigen in advanced prostate cancer. Clin Cancer Res 2000 May;6(5):1632­8.
Edmunds W, Dejene A, Mekonnen Y, Haile M, Alemnu W, Nokes D. The cost of integrating hepatitis B virus vaccine into national immunization
programmes: a case study from Addis Ababa. Health Policy Plan 2000 Dec;15(4):408­16
Edmunds WJ, Gay NJ. Health professionals do not understand mathematical models [letter]. BMJ 2000; 320(7234):581­582.
Edwards EA, Grant CC, Huang QS, Powell KF, Croxson MC. A case of vaccine­associated paralytic poliomyelitis. J Paediatr Child Health 2000
Aug;36(4):408­11.
Edwards, E. A., Grant, C. C., Huang, Q. S., Powell, K. F., and Croxson, M. C. A case of vaccine­associated paralytic poliomyelitis. J Paediatr Child Health
2000 Aug;36(4):408­11
Ehresmann KR, Mills WA, Loewenson PR, Moore KA. Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications
for public health and provider education. Am J Public Health 2000 Dec;90(12):1917­20
Ekwueme DU, Strebel PM, Hadler SC, Meltzer MI, Allen JW, Livengood JR. Economic evaluation of use of diphtheria, tetanus, and acellular pertussis
vaccine or diphtheria, tetanus, and whole­cell pertussis vaccine in the United States, 1997. Arch Pediatr Adolesc Med 2000 Aug;154(8):797­803.
El Kasmi KC, Fillon S, Theisen DM, Hartter H, Brons NH, Muller CP. Neutralization of measles virus wild­type isolates after immunization with a synthetic
peptide vaccine which is not recognized by neutralizing passive antibodies. J Gen Virol 2000; 81 Pt 3:729­735.
Elliman, D.; Bedford, H. Perhaps it is not time to switch from whole cell to acellular pertussis vaccine [letter]. BMJ 2000 Aug 12;321(7258):451­2.
Ellner JJ, Hirsch CS, Whalen CC. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis 2000 Jun;30 Suppl 3:S279­82.
Elphinstone, P. The MMR question [letter]. Lancet 2000 Jul 8;356(9224):161.
Emerton D. Unexpected beneficial effects of measles immunization. Socioeconomic confounding may also play a part [letter]. BMJ 2000; 320(7239):938­940.
Engels EA, Bennish ML, Falagas ME, Lau J. Typhoid fever vaccines [letter]. Vaccine 2000;1433­4.
Engler T. Unexpected beneficial effects of measles immunisation. Who brought measles? [letter]. BMJ 2000; 320(7239):939­940.
Enserink M. Global health. Group urges action on Third World drugs [news]. Science 2000;1571.
Erramouspe J, Heyneman CA. treatment and prevention of otitis media. Ann Pharmacother 2000 Dec;34(12):1452­68
Eskola J, Kilpi T. Potential of bacterial vaccines in the prevention of acute otitis media. Pediatr Infect Dis J 2000 May;19(5 Suppl):S72­8.
Fabrizi F, Martin P. Hepatitis B virus infection in dialysis patients. Am.J.Nephrol. 2000;1­11.
Feavers IM. ABC of meningococcal diversity [news; comment]. Nature 2000; 404(6777):451­452.
Fee E, Brown TM. The microbial menace, then and now [editorial]. Am.J.Public Health 2000;184­5.
Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal
exemptions to immunization. JAMA 2000 Dec 27;284(24):3145­50
Felt BT, Mollen E, Diaz S, Renaud E, Zeglis M, Wheatcroft G, Mendelow D. Behavioral interventions reduce infant distress at immunization. Arch Pediatr
Adolesc Med 2000 Jul;154(7):719­24.
Ferson MJ. Adult vaccination: old needs, new challenges and opportunities [editorial; comment]. Med J Aust 2000 Jul 17;173(2):72­3.
Filonov VP, Zakharenko DF, Vitek CR, Romanovsky AA, Zhukovski VG. Epidemic diphtheria in Belarus, 1992­1997. J Infect Dis 2000; 181 Suppl 1:S41­
S46.
Finlay R. Unexpected beneficial effects of measles immunisation. Number of squint operations has decreased [letter]. BMJ 2000; 320(7239):939­940.
Fischman J. Vaccinating against paralysis. US News World Rep 2000 Dec 25;129(25):66­7
FitzGerald JM, Wang L, Elwood RK. Tuberculosis: 13. Control of the disease among aboriginal people in Canada. CMAJ. 2000;351­5.
FitzGerald, D. and Mrsny, R. J. New approaches to antigen delivery. Crit Rev Ther Drug Carrier Syst 2000;17(3):165­248
Flehmig B, Normann A, Bohnen D. Transmission of hepatitis A virus infection despite vaccination. N Engl J Med. 2000 Jul 27;343(4):301­2.
Frank­Peterside, N. Response of laboratory staff to vaccination with an inactivated rift valley fever vaccine­­TSI­GSD 200 Afr.J.Med.Med.Sci. 2000, 29 (2):
89­92.
Franzen D. Clinical Efficacy of Pneumococcal Vaccination ­ A Prospective Study in Patients with Longstanding Emphysema and / or Bronchitis. Eur J Med
Res 2000 Dec 29;5(12):537­40
Franzini L, Rosenthal J, Spears W, Martin HS, Balderas L, Brown M, Milne G, Drutz J, Evans D, Kozinetz C, et al. Cost­effectiveness of childhood
immunization reminder/recall systems in urban private practices. Pediatrics 2000 Jul;106(1 Pt 2):177­83.
Frasch CE, Concepcion NF. Specificity of human antibodies reactive with pneumococcal C polysaccharide. Infect Immun 2000; 68(4):2333­2337.
French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. 23­valent pneumococcal
polysaccharide vaccine in HIV­1­infected Ugandan adults: double­blind, randomised and placebo controlled trial. Lancet 2000 Jun 17;355(9221):2106­11.
Fried RG. Health consequences of exemptions from immunization laws [letter]. JAMA 2000;1140­2.
Friedman HM. Immunologic strategies for herpes vaccination [letter]. JAMA 2000;746­7.
Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men
who have sex with men. Am J Public Health 2000 Dec;90(12):1942­6
Friedrich F. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of
poliovirus. Acta Virol 2000 Apr;44(2):109­17.
From the Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the
2000­01 influenza season. Advisory Committee on Immunization Practices. JAMA 2000 Aug 9;284(6):687­8.
From the Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the
2000­01 influenza season. Advisory Committee on Immunization Practices. JAMA 2000 Aug 9;284(6):687­8.
From the Centers for Disease Control and Prevention. Global measles control and regional elimination, 1998­1999. JAMA 2000;472­4.
From the Centers for Disease Control and Prevention. National, state and urban area vaccination coverage levels among children aged 19­35 months­­United
States, 1999. JAMA 2000 Aug 9;284(6):690.
From the Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication­­European Region 1998­June 2000. JAMA 2000 Aug
16;284(7):824­5.
From the Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication­­Eastern Mediterranean Region, 1998­October 1999. JAMA
2000;195­6.
From the Centers for Disease Control and Prevention. Update: expanded availability of thimerosal preservative­free hepatitis B vaccine. JAMA 2000 Aug 23­
2000 Aug 30;284(8):954.
Fry DE. Hepatitis: risks for the surgeon. Am.Surg. 2000;178­83.
Galama, J. M. Vaccinations as risk factors for Type I diabetes mellitus [letter]. Diabetologia 2000 May;43(5):684.